Squarepoint’s Boundless Bio BOLD Stock Holding History

Squarepoint’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18K	Buy	+16,374	New	+$19.1K	﹤0.01%	4178
2025 Q4	–	Sell	-50,771	Closed	-$62.4K	–	5016
2025 Q3	$62.4K	Buy	50,771 +32,372	+176%	+$37.4K	﹤0.01%	4192
2025 Q2	$18.6K	Buy	+18,399	New	+$24.4K	﹤0.01%	4393
2025 Q1	–	Sell	-32,182	Closed	-$93.3K	–	5567
2024 Q4	$93.3K	Buy	32,182 +932	+3%	+$2.72K	﹤0.01%	4714
2024 Q3	$108K	Hold	31,250	–	–	﹤0.01%	3855
2024 Q2	$121K	Hold	31,250	–	–	﹤0.01%	3760
2024 Q1	$445K	Buy	+31,250	New	+$445K	﹤0.01%	3129

Other funds holding BOLD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Squarepoint's BOLD Position: Q1 2026 in Review

Squarepoint opened a new position in Boundless Bio (BOLD) in Q1 2026: 16,374 shares worth $18K. The stake represents ﹤0.01% of the portfolio and ranks #4178 among its holdings. This is a return to the name: Squarepoint previously reported a position in BOLD as recently as Q3 2025.

Squarepoint first reported a position in BOLD in Q1 2024 and has held it in 7 quarters since. The position peaked at $445K in Q1 2024. 36 funds tracked by Wall St. Rank hold BOLD as of Q1 2026.

Squarepoint held 16,374 shares of Boundless Bio worth $18K as of Q1 2026.
Boundless Bio was a new Squarepoint position in Q1 2026.
Boundless Bio made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #4178 holding.
Squarepoint first reported a position in Boundless Bio in Q1 2024 and has held it in 7 quarters since.
Squarepoint's Boundless Bio position peaked at $445K in Q1 2024.
36 funds tracked by Wall St. Rank held Boundless Bio as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.